ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 101003 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 101003; 2) Community: the network communities that were significantly associated with the response to NSC 101003; 3) Molecule: the relationships between components within communities and NSC 101003; 4) MDR: the compounds that were significantly associated with the NSC 101003.

NSC Compound Enrichment Correlation
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0220292715546633 -0.26940723
NSC 756140 GSK1220512A 0.0220292715546633 0.040740253
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0228506033927957 0.40115659
NSC 16258 Null 0.0228506033927957 0.27033105
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0228506033927957 0.32095143
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0228506033927957 0.43098384
NSC 215721 Null 0.0228506033927957 0.55479686
NSC 264880 Dihydro-5-azacytidine 0.0228506033927957 0.026414847
NSC 328785 ANTINEOPLASTIC-328785 0.0228506033927957 0.40485267
NSC 348977 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide, dihydrochloride 0.0228506033927957 0.46334194
Total:105  Current:58    [First] [Prev] [Next] [Last]